$64.49 -1.10 (%) Charles River Laboratories International Inc - NYSE

Nov. 25, 2014 | 04:00 PM

Partner Headlines

  1. Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE

    Benzinga | Nov. 4, 2014 | 05:22AM EST
  2. John Rogers Comments on Charles River Laboratories Intl Inc

    GuruFocus | Jul. 22, 2014 | 17:06PM EST
  3. John Rogers' Ariel Fund Second Quarter 2014 Commentary

    GuruFocus | Jul. 22, 2014 | 16:51PM EST
  4. Charles River Aims To Be 'One-Stop Shop' With Buyout

    IBD | Mar. 13, 2014 | 11:39AM EST
  5. Morgan Stanley Feels Confidence in Charles River Laboratories Following Solid 4Q13 EPS Report

    Benzinga | Feb. 12, 2014 | 09:36AM EST
  6. CHARLES RIVER LABS

    IBD | Feb. 11, 2014 | 18:34PM EST
  7. Earnings Scheduled For February 11, 2014

    Benzinga | Feb. 11, 2014 | 04:34AM EST
  8. Parexel Plunges After 3 CROs Report Earnings

    IBD | Oct. 30, 2013 | 11:41AM EST
  9. Parexel Stock Rises As Analyst Upgrades, Touts CROs

    IBD | Oct. 4, 2013 | 12:25PM EST
  10. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  11. Medical Research Firms Tap Drug Development Trend

    IBD | Aug. 30, 2013 | 16:40PM EST
  12. Earnings Scheduled For February 13, 2013

    Benzinga | Feb. 12, 2013 | 19:13PM EST
  13. Robert Olstein's Largest New Stock Picks

    GuruFocus | Feb. 12, 2013 | 08:48AM EST
  14. UPDATE: Sterne Agee Reiterates Buy Rating, Raises PT on Charles River Laboratories

    Benzinga | Jan. 14, 2013 | 07:10AM EST
  15. Weekly CFO Sells HIGHLIGHT: TMO, BLOX, VRSK, CRL, INGR, GWRE

    GuruFocus | Jan. 13, 2013 | 11:44AM EST
  16. Charles River Laboratories International Inc (CRL) Corp. ...

    GuruFocus | Jan. 8, 2013 | 06:34AM EST
  17. Charles River Labs Closes Purchase of Majority Ownership of Vital River

    Benzinga | Jan. 7, 2013 | 10:00AM EST
  18. UPDATE: JP Morgan Upgrades Charles River Laboratories to Overweight on Risk/Reward

    Benzinga | Dec. 13, 2012 | 05:06AM EST
  19. Mid-Afternoon Market Update: Bernanke Press Conference Leads to Drop in the Markets

    Benzinga | Dec. 12, 2012 | 08:56AM EST
  20. Mid-Day Market Update: Fed to Continue Stimulus, Markets Rise

    Benzinga | Dec. 12, 2012 | 07:26AM EST
  21. UPDATE: ISI Group Cuts PT to $39 on Charles River Laboratories Following Negative Guidance

    Benzinga | Dec. 12, 2012 | 06:41AM EST
  22. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest ROA

    Benzinga | Dec. 6, 2012 | 20:44PM EST
  23. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus | Nov. 1, 2012 | 06:02AM EST
  24. UPDATE: Jefferies & Company Reiterates Hold Rating, Raises PT on Charles River Laboratories

    Benzinga | Oct. 31, 2012 | 06:06AM EST
  25. Top 4 NYSE Stocks In The Biotechnology Industry With The Highest Revenue Estimates

    Benzinga | Oct. 23, 2012 | 21:27PM EST
  26. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Oct. 3, 2012 | 11:00AM EST
  27. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Oct. 3, 2012 | 11:00AM EST
  28. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus | Oct. 3, 2012 | 09:00AM EST
  29. Charles River Opens New Biomedical Diagnostic Facility

    Benzinga | Sep. 6, 2012 | 02:41AM EST
  30. Charles River Acquires Accugenix

    Benzinga | Aug. 29, 2012 | 08:00AM EST
  31. Charles River Laboratories International Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 14:28PM EST
  32. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus | Jul. 12, 2012 | 10:10AM EST
  33. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Jul. 10, 2012 | 13:20PM EST
  34. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Jul. 10, 2012 | 13:20PM EST
  35. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Jul. 10, 2012 | 13:20PM EST
  36. Charles River Laboratories International (CRL) Chairman, President and CEO James C Foster sells ...

    GuruFocus | Jul. 10, 2012 | 13:20PM EST
  37. Health Care Sector Wrap

    FoxBusiness | Jul. 6, 2012 | 10:51AM EST
  38. Charles River Laboratories International (CRL) Corp. ...

    GuruFocus | Jul. 5, 2012 | 08:21AM EST
  39. Charles River Labs

    IBD | Feb. 13, 2012 | 11:24AM EST
  40. Ariel Funds Top Buys: "We think like Halvorsen: CRL is a buy"

    GuruFocus | Jan. 11, 2012 | 08:05AM EST
  41. Stocks I Can Buy Much Cheaper Than Halvorsen Did

    GuruFocus | Jan. 11, 2012 | 07:46AM EST
  42. Ken Heebner Top Holdings: AAPL Is a Buy at $380

    GuruFocus | Jan. 11, 2012 | 03:20AM EST
  43. Benzinga's M&A Chatter for Tuesday January 10, 2012

    Benzinga | Jan. 10, 2012 | 11:43AM EST
  44. Charles River rises on sale talk

    IBD | Jan. 10, 2012 | 11:31AM EST
  45. JP Morgan Reiterates BioMimetic Therapeutics Neutral

    Benzinga | Jan. 4, 2012 | 06:05AM EST
  46. Citigroup Lowers PT on Charles River Laboratories to $31

    Benzinga | Dec. 14, 2011 | 22:50PM EST
  47. UPDATE: Deutsche Bank Lowers PT on Charles River Laboratories to $28

    Benzinga | Dec. 14, 2011 | 04:25AM EST
  48. Deutsche Bank Maintains Hold After Charles River Releases 2012 Guidance

    Benzinga | Dec. 14, 2011 | 00:49AM EST
  49. Notable Call Options Activity in Charles River Laboratories

    Benzinga | Dec. 12, 2011 | 03:07AM EST
Trading Center